Jeffrey Bertolini, an officer at Carlsmed, Inc., has filed a Form 144 to sell 747 shares of the company's common stock. This transaction occurred on November 3, 2026, and is part of a stock option exercise. The aggregate market value of the shares sold is approximately $11,317.05.

This filing is significant as it reflects Bertolini's ongoing liquidity management strategy and provides insight into executive actions within the company. The surgical and medical instruments industry, represented by Carlsmed, may view such transactions as indicative of market confidence or personal financial planning among executives.

Background

Carlsmed, Inc. is classified under the SIC code for Surgical & Medical Instruments & Apparatus. The company is incorporated in Delaware and has its business address at 1800 Aston Avenue, Suite 100, Carlsbad, CA 92008. As of the latest filings, Carlsmed is listed on NASDAQ under the SEC file number 001-42756.

What the Filing Says

The filing indicates that Bertolini acquired the shares through a stock option exercise on the same date as the sale. The notice signature was provided by Daniel Tucci, representing Fidelity Brokerage Services LLC, as attorney-in-fact for Bertolini.

Impact

This filing may affect shareholders and potential investors by providing transparency into executive transactions. It also highlights the liquidity strategies employed by executives in the surgical and medical instruments sector.

What's Next

The filing does not say what happens next.